Trinity Biotech (TRIB) Other Non-Current Liabilities (2022 - 2025)

Trinity Biotech's Other Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $781000.0 for Q4 2025.

• In Q4 2025, Other Non-Current Liabilities rose 941.33% year-over-year to $781000.0; the TTM figure through Dec 2025 stood at $781000.0 (up 941.33% YoY), while the FY2025 annual figure was $781000.0, up 941.33% from the prior year.
• Other Non-Current Liabilities came in at $781000.0 for Q4 2025 at Trinity Biotech, down from $1.8 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $2.0 million in Q2 2022 to a low of $75000.0 in Q4 2024.
• A 4-year average of $1.3 million and a median of $1.5 million in 2023 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities tumbled 85.74% in 2024 and surged 941.33% in 2025, its largest moves.
• Trinity Biotech's Other Non-Current Liabilities stood at $1.6 million in 2022, then tumbled by 66.48% to $526000.0 in 2023, then sank by 85.74% to $75000.0 in 2024, then soared by 941.33% to $781000.0 in 2025.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $781000.0, $1.8 million, and $75000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison